Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity.
Saved in:
| Title: | Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. |
|---|---|
| Authors: | Lanzon B; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain., Martin-Taboada M; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain., Castro-Alves V; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden., Vila-Bedmar R; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain., González de Pablos I; Department of Nephrology, University Hospital 12 de Octubre, 28041 Madrid, Spain., Duberg D; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden., Gomez P; Department of Surgery, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain., Rodriguez E; Department of Surgery, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain., Orešič M; School of Medical Sciences, Örebro University, 702 81 Örebro, Sweden.; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland., Hyötyläinen T; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden., Morales E; Department of Nephrology, University Hospital 12 de Octubre, 28041 Madrid, Spain.; Research Institute of University Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Department of Medicine, Complutense University of Madrid, 28041 Madrid, Spain., Ruperez FJ; Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, 28668 Boadilla del Monte, Spain., Medina-Gomez G; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.; LAFEMEX Laboratory, Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain. |
| Source: | Metabolites [Metabolites] 2021 Dec 03; Vol. 11 (12). Date of Electronic Publication: 2021 Dec 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101578790 Publication Model: Electronic Cited Medium: Print ISSN: 2218-1989 (Print) Linking ISSN: 22181989 NLM ISO Abbreviation: Metabolites Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34940593 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lanzon+B%22">Lanzon B</searchLink>; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22Martin-Taboada+M%22">Martin-Taboada M</searchLink>; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22Castro-Alves+V%22">Castro-Alves V</searchLink>; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Vila-Bedmar+R%22">Vila-Bedmar R</searchLink>; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22González+de+Pablos+I%22">González de Pablos I</searchLink>; Department of Nephrology, University Hospital 12 de Octubre, 28041 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Duberg+D%22">Duberg D</searchLink>; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Gomez+P%22">Gomez P</searchLink>; Department of Surgery, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez+E%22">Rodriguez E</searchLink>; Department of Surgery, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Orešič+M%22">Orešič M</searchLink>; School of Medical Sciences, Örebro University, 702 81 Örebro, Sweden.; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Hyötyläinen+T%22">Hyötyläinen T</searchLink>; School of Science and Technology, Örebro University, 702 81 Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Morales+E%22">Morales E</searchLink>; Department of Nephrology, University Hospital 12 de Octubre, 28041 Madrid, Spain.; Research Institute of University Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Department of Medicine, Complutense University of Madrid, 28041 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ruperez+FJ%22">Ruperez FJ</searchLink>; Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, 28668 Boadilla del Monte, Spain.<br /><searchLink fieldCode="AU" term="%22Medina-Gomez+G%22">Medina-Gomez G</searchLink>; LIPOBETA Group, Department Basic Sciences of Health, Faculty of Sciences of Health, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.; LAFEMEX Laboratory, Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101578790%22">Metabolites</searchLink> [Metabolites] 2021 Dec 03; Vol. 11 (12). <i>Date of Electronic Publication: </i>2021 Dec 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101578790 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2218-1989 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222181989%22">22181989 </searchLink><i>NLM ISO Abbreviation: </i>Metabolites <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34940593 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/metabo11120836 Languages: – Code: eng Text: English Titles: – TitleFull: Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lanzon B – PersonEntity: Name: NameFull: Martin-Taboada M – PersonEntity: Name: NameFull: Castro-Alves V – PersonEntity: Name: NameFull: Vila-Bedmar R – PersonEntity: Name: NameFull: González de Pablos I – PersonEntity: Name: NameFull: Duberg D – PersonEntity: Name: NameFull: Gomez P – PersonEntity: Name: NameFull: Rodriguez E – PersonEntity: Name: NameFull: Orešič M – PersonEntity: Name: NameFull: Hyötyläinen T – PersonEntity: Name: NameFull: Morales E – PersonEntity: Name: NameFull: Ruperez FJ – PersonEntity: Name: NameFull: Medina-Gomez G IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 12 Text: 2021 Dec 03 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2218-1989 Numbering: – Type: volume Value: 11 – Type: issue Value: 12 Titles: – TitleFull: Metabolites Type: main |
| ResultId | 1 |